Suraksha Diagnostic Share Price

NSE
SURAKSHA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Suraksha Diagnostic
Suraksha Diagnostic Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Suraksha Diagnostic Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
42.27% Fall from 52W High
-30.8
Dividend yield 1yr %
0

Suraksha Diagnostic Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Suraksha Diagnostic Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
59.51 Cr
66.75 Cr
60.73 Cr
55.19 Cr
51.82 Cr

Suraksha Diagnostic Yearly Revenue

Mar 2024Mar 2023Mar 2022
222.26 Cr
193.69 Cr
225.77 Cr

Suraksha Diagnostic Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
5.98 Cr
10.16 Cr
7.67 Cr
6.32 Cr
4.54 Cr

Suraksha Diagnostic Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022
23.13 Cr
6.06 Cr
20.82 Cr
Suraksha Diagnostic Result Highlights
  • Suraksha Diagnostic Ltd reported a 11.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 14.1%.

  • Its expenses for the quarter were down by 4.4% QoQ and up 12.1% YoY.

  • The net profit decreased 41.1% QoQ and increased 32.0% YoY.

  • The earnings per share (EPS) of Suraksha Diagnostic Ltd stood at 1.2 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Suraksha Diagnostic shareholding Pattern

Promoter
48.8%
Foreign Institutions
15.4%
Mutual Funds
17.6%
Domestic Institutions
20.4%
Public
15.4%

Suraksha Diagnostic Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
11
5Day EMA
267.70
10Day EMA
273.00
12Day EMA
274.20
20Day EMA
278.80
26Day EMA
282.90
50Day EMA
304.10
EMA
EMA
5Day SMA
269.80
10Day SMA
279.10
20Day SMA
274.50
30Day SMA
280.70
50Day SMA
298.50
SMA
SMA
SMA
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
73990 Rs
128407 Rs
Week Rs
84284 Rs
136082 Rs
Month Rs
71077 Rs
157428 Rs
Resistance & Support
260.72
Pivot
Resistance
First Resistance
265.98
Second Resistance
272.77
Third Resistance
278.03
Support
First Support
253.93
Second support
248.67
Third Support
241.88
Relative Strength Index
34.53
Money Flow Index
38.93
MACD
-8.70
MACD Signal
-8.64
Average True Range
14.50
Average Directional Index
35.40
Rate of Change (21)
-10.08
Rate of Change (125)
0.00

Suraksha Diagnostic Company background

Founded in: 2005
Managing director: Ritu Mittal
Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata. Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited, and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India. In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors. The diagnostic test menu included (a) 788 routine pathology tests ranging from basic biochemistry andhematology to 647 specialized pathology tests such as advanced biochemistry, histopathology, and molecular pathology, and (b) 748 basic/intermediate radiology tests ranging from basic xrays, ultrasonography (USG), and computerized tomography (CT) scans to 104 advanced radiology tests such as magnetic resonance imaging (MRI) scans and specialized CT scans.The first centre of the Company was launched at Kestopur in 2007. The second centre launched at Khardah in 2010, which increased the operating centres to 5. The Company increased the laboratories to 4 and the operating centres rose to 25 in 2016. The Company further acquired the business of Sunwell Diagnostic Private Limited in 2017. The operations to Meghalaya were expanded through a publicprivate partnership with the Government of Meghalaya in 2019. Further, 2 preexisting diagnostic centres in Kolkata were acquired by the Company from Future Medical and Research Trust in 2020. And the first 3T MRI and 128 CT launched at New Town in 2023. The Company is planning the Public Issue upto 19,189,330 Equity Shares through Offer for Sale.
Read More

Suraksha Diagnostic FAQs

Suraksha Diagnostic share price is ₹259.2 in NSE and ₹257.8 in BSE as on 27/3/2025.

Suraksha Diagnostic share price in the past 1-year return was 0. The Suraksha Diagnostic share hit a 1-year low of Rs. 231 and a 1-year high of Rs. 449.

The market cap of Suraksha Diagnostic is Rs. 1349.93 Cr. as of 27/3/2025.

The PE ratios of Suraksha Diagnostic is 40.6 as of 27/3/2025.

The PB ratios of Suraksha Diagnostic is 6.66 as of 27/3/2025

The Mutual Fund Shareholding in Suraksha Diagnostic was 17.64% at the end of 27/3/2025.

You can easily buy Suraksha Diagnostic shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Suraksha Diagnostic stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -